Saltar al contenido principal
Pan y Hierro Nutrition and exercise with sources

Strength

Polycystic ovary syndrome and strength: what it says and what it does not

What the lean mass meta-analysis found in PCOS, why the difference is explained by weight, and what the strength training evidence offers.

Polycystic ovary syndrome (PCOS) is the most common chronic endocrinopathy and a frequent cause of infertility. If you have the diagnosis and you train strength, the question you will ask yourself is not “can I train?” but “what changes in my body and what might help me?” The evidence here is clearer than on other women’s health topics, and it also has a very clear limit: there is a solid meta-analysis on muscle mass and very little on strength programs.

What the muscle mass meta-analysis says

Kazemi and colleagues published a meta-analysis in the *Journal of the Endocrine

What the muscle mass meta-analysis says: Measure · Weighted mean difference (95% CI) · p
Measure Weighted mean difference (95% CI) p
Total lean mass +0.83 kg (0.08 to 1.58) 0.03
Trunk lean mass +0.84 kg (-0.37 to 2.05) 0.15
BMI ≥ 25 subgroup: total lean mass +1.58 kg (0.82 to 2.34) < 0.01
BMI < 25 subgroup: total lean mass -0.45 kg (-1.94 to 1.05) 0.53

Read carefully, these four rows tell a fairly simple story. Women with PCOS have somewhat more total lean mass [1]. But the trunk mass interval crosses zero, so there is no difference there [1]. And the subgroup analysis explains the reason: when you split by BMI, the difference only appears in the group with overweight or obesity (+1.58 kg) and disappears completely in the lean group (-0.45 kg; CI that includes zero) [1].

The authors’ conclusion is explicit and dismantles a widespread belief: hyperandrogenism does not protect muscle mass. In the metaregression analyses there was no association between total testosterone or HOMA-IR differences and total or trunk lean mass (all p ≥ 0.75) [1]. And heterogeneity between studies was high (I² = 72.0% for total lean mass) [1], which the work itself flags as a reason not to overinterpret.

The weak side: strength programs

Here the evidence is considerably poorer than the search volume suggests. Wright and colleagues’ scoping review, in the International Journal of Exercise Science (2021), looked for studies on strength training in women with PCOS between 2011 and 2021 [2]. Of the articles found, only 9 met the criteria, and here is the important part: 7 of those 9 were substudies of the same large clinical trial. Only one was a small randomized trial and another a feasibility study [2].

The weak side: strength programs: What the review finds · Detail
What the review finds Detail
Articles included 9
Substuddies of the same trial 7
Sample sizes Small, and assessing different variables

Every intervention gave positive results across a broad range of variables, but the authors rate the evidence as positive but preliminary [2]. Their conclusion is that trials with adequate statistical power are needed to confirm the benefits, to answer what the therapeutic dose is and to find strategies that support adherence [2].

Honest translation: there are reasons to train strength, but we still do not know with which program. If you are diagnosed with PCOS, the general public health recommendation stays the same as for any adult, and the PCOS review collects it as first-line treatment without specifying the type of exercise [2].

Which prescription applies

Which prescription applies: Goal · Reference prescription · Source
Goal Reference prescription Source
Strength Heavy loads, 2-3 sets, ≥ 2 sessions/week [3]
Hypertrophy ≥ 10 weekly sets [3]
General health ≥ 2 days/week of physical activity [4]

One practical point that comes out of the data and is worth not losing: if you have PCOS and you are overweight, the meta-analysis suggests that part of your lean mass is already higher than that of controls of the same weight [1]. That is not more trained muscle: it is total lean mass, which includes water and connective tissue. To keep training real muscle, measure against your own previous weeks, with the 1RM calculator or with skinfold measurements, and do not rely on the scale alone.

And two warnings that go beyond strength:

  • PCOS often comes with insulin resistance. That is a medical and metabolic issue: treatment, if there is any, is decided by your endocrinologist or gynecologist, not by a training plan.
  • If PCOS comes with very irregular or absent cycles, the article on the menstrual cycle and strength does not apply: its studies are in women with regular cycles [1]. There is nothing here that justifies a different program. The American College of Sports Medicine position stands gives the same references as for the rest of the healthy adult population: for strength, 2-3 sets and **at least 2 sessions per

In short

  1. The meta-analysis of 45 studies (3,676 women) finds +0.83 kg of total lean mass in PCOS, but the trunk interval crosses zero [1].
  2. When split by BMI, the difference only appears at BMI ≥ 25 (+1.58 kg) and disappears in the lean group (-0.45 kg) [1]. In other words, weight explains it.
  3. Hyperandrogenism does not protect muscle mass: there was no association with total testosterone or HOMA-IR (p ≥ 0.75) [1].
  4. On strength programs, the evidence is positive but preliminary: 9 articles, 7 from the same trial, small samples [2].
  5. The prescription is the same as for any adult: 2-3 sets and ≥ 2 sessions per week [3], ≥ 2 days per week as public health [4].

To start with the practical side, you have the available routines and the exercise catalog. Treatment of PCOS and of its metabolic manifestations is a medical decision, not something this article decides. week**; for hypertrophy, at least 10 weekly sets [3]. And the WHO public health recommendation remains 2 or more days per week [4]. Society* in 2021, as part of the work of the international PCOS guideline [1]. They reviewed 45 studies with 3,676 women (1,854 with PCOS and 1,822 controls): 41 assessed lean mass and 5 assessed strength [1]. These are the results:

Related articles

Sources for this article (4) 4 references
  1. Kazemi M, Pierson RA, Parry S, Kaviani M, Chilibeck PD (2021) Skeletal Muscle Health in Polycystic Ovary Syndrome: Protective Effect of Hyperandrogenism or Detrimental Effect of Insulin Resistance? A Systematic Review and Meta-Analysis. Journal of the Endocrine Society 5(Suppl 1):A744-A745. See source (opens in a new tab) DOI: 10.1210/jendso/bvab048.1514 Metaanálisis de 45 estudios (n = 3.676) de masa magra en SOP: 0,83 kg más de masa magra total, atribuida al IMC; con IMC ≥ 25 fueron 1,58 kg más y en el subgrupo magro no hubo diferencia Licence: Artículo de acceso abierto bajo Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND), Oxford University Press para la Endocrine Society. Se cita con enlace. Consulted:
  2. Wright PJ, Corbett CF, Pinto BM, Dawson RM, Wirth M (2021) Resistance Training as Therapeutic Management in Women with PCOS: What is the Evidence?. International Journal of Exercise Science 14(3):840-854. See source (opens in a new tab) DOI: 10.70252/NEEX8658 Revisión de alcance de 9 artículos (7 subestudios de un mismo ensayo): evidencia positiva pero preliminar; tamaños muestrales pequeños y variables de resultado distintas Licence: Artículo de acceso abierto depositado en PubMed Central. Se cita con enlace; no se reproduce texto salvo cita breve verificable. Consulted:
  3. Currier BS, D'Souza AC, Singh MAF, et al. (2026) American College of Sports Medicine Position Stand. Resistance Training Prescription for Muscle Function, Hypertrophy, and Physical Performance in Healthy Adults: An Overview of Reviews. Med Sci Sports Exerc 58(4):851-872. See source (opens in a new tab) DOI: 10.1249/MSS.0000000000003897 Posicionamiento del ACSM (visión general de 137 revisiones) que actualiza el de 2009: fuerza con cargas pesadas, 2-3 series y al menos 2 sesiones por semana; hipertrofia con al menos 10 series semanales Licence: Artículo de revista con derechos de autor. Se cita con enlace al editor; no se reproduce texto salvo cita breve verificable. Consulted:
  4. Bull FC, Al-Ansari SS, Biddle S, et al. (2020) World Health Organization 2020 guidelines on physical activity and sedentary behaviour. British Journal of Sports Medicine 54(24):1451-1462. See source (opens in a new tab) DOI: 10.1136/bjsports-2020-102955 Guía de la OMS 2020 (recomendaciones con GRADE; texto libre en PMC) Licence: Artículo de acceso abierto (BMJ, CC BY 4.0). Guía oficial en PDF: who.int/publications/i/item/9789240015128. Se cita con enlace. Consulted:

How to cite

Pan y Hierro (2026). Polycystic ovary syndrome and strength: what it says and what it does not. https://panyhierro.com/en/strength/women/polycystic-ovary-syndrome-and-strength/. Updated October 4, 2026.